Esketamine in Treatment-Resistant Depression and Suicidal Ideation: A Systematic Review

Background. Major depressive disorder affects 20% of the global population, with treatment-resistant depression in 10-30% of cases. Patients with acute suicidal ideation need immediate intervention, yet conventional antidepressants require weeks to work. Esketamine offers rapid symptom reduction th...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Natalia Dudziak, Zuzanna Drozd, Bartosz Niemiec, Szymon Piosik, Bruno Olesiński, Łukasz Piasecki, Zuzanna Guzowicz, Monika Kamińska, Patrycja Gągałka
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Kazimierz Wielki University 2025-11-01
Edice:	Journal of Education, Health and Sport
Témata:	esketamine treatment-resistant depression suicidal ideation NMDA receptor ketamine
On-line přístup:	https://apcz.umk.pl/JEHS/article/view/66740
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!